Disease Information & Support


The Word:


Generic name Plerixafor
Pronunciation ple-RIK-sa-fore
Brand name(s), other common name(s) Mozobil®
Drug type  Stem cell mobilizer
How the drug is given Subcutaneous (SC) injection

Plerixafor injection is FDA approved for use along with a granulocyte colony-stimulating factor (G-CSF) medication in preparation for an autologous stem cell transplant in patients with non-Hodgkin lymphoma or myeloma. Plerixafor injection works by causing certain blood cells to move from the bone marrow to the blood so that they can be removed for transplantation.

Side effects needing medical attention: Diarrhea; nausea; tiredness (fatigue); injection site reaction; headache; pain in the joints (arthralgia); dizziness; vomiting.


For information on how to manage the costs of drug therapy, please see Financial Matters and Prescription Drug Coverage, or to speak with an Information Specialist, call (800) 955-4572.

last updated on Monday, October 15, 2012